Biocon Biologics to Acquire Viatris’ Biosimilars Assets for up to USD 3.335 billion in Stock and Cash
BENGALURU, India, Feb. 28, 2022 /PRNewswire/ -- Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523) (NSE: BIOCON), has entered into a definitive agreement with its partner Viatris Inc. (NASDAQ: VTRS). Accordingly, Biocon Biologics Ltd. (BBL) will acquire Viatris' biosimilars business to create a unique fully integrated global biosimilars enterprise....
Inspira Technologies Applauded by Frost & Sullivan for Minimizing the Need for Invasive Mechanical Ventilation with Its Innovative Technology, the ART™ System
Inspira Technologies aims to set a new standard of care in the respiratory care industry by introducing its ART system. SAN ANTONIO, Feb. 28, 2022 /PRNewswire/ -- Frost & Sullivan recently analyzed the European artificial respiratory market and, based on its findings, recognizes Inspira Technologies (Nasdaq: IINN/IINNW) with the 2021 Europe Technology Innovation Leadership Award. The company provides innovative...
PHASE II CLINICAL STUDY AT WEILL CORNELL MEDICAL CENTER INVESTIGATING PAXALISIB IN COMBINATION WITH METFORMIN AND A KETOGENIC DIET ENROLLS FIRST PATIENT
SYDNEY, Feb. 28, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that a phase II study of Kazia's investigational new drug, paxalisib, in combination with metformin and a ketogenic diet for the treatment of newly diagnosed and recurrent glioblastoma, has been initiated...
The Best Taiwan Postpartum Nursing Care Centers & Confinement Meals Brands Recommended by MamiGuide Golden Award
KUALA LUMPUR, Malaysia, Feb. 28, 2022 /PRNewswire/ -- Greeting the arrival of a newborn is always the most important to pregnant mothers. According to MamiGuide's online survey, nearly 65% of postpartum mothers choose to go to postpartum nursing centers for confinement, and 15% choose to order confinement meals. The demand for high-level confinement services due to low birthrate has...
Argon Medical Devices Celebrates Its 50th Anniversary
Industry leader highlights its longevity and thanks employees for their loyalty and effort FRISCO, Texas, Feb. 28, 2022 /PRNewswire/ -- Argon Medical Devices, Inc., a leading manufacturer of medical devices for interventional procedures, announces its 50th anniversary. This impressive milestone speaks to the dedication of the company's employees who take pride...
Stena RoRo has built the world’s largest civilian hospital ship – the Global Mercy is now calling Rotterdam
STOCKHOLM, Feb. 28, 2022 /PRNewswire/ -- From February 28 to March 14, the world's largest hospital ship, the Global Mercy, will be in Rotterdam. A momentous event for Stena RoRo who, on behalf of the charity Mercy Ships, has been the project manager for the ship's construction since 2013. During her weeks in Rotterdam, the newly built ship will...
Transcenta Announces First Patient Dosed in Phase IIa Study of Claudin18.2 Monoclonal Antibody TST001 Combined with Cisplatin and Gemcitabine for the First Line Treatment of Biliary Tract Cancer
SUZHOU, China, Feb. 28, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the successful dosing of first patient in China Phase IIa Study of TST001, a Claudin18.2 monoclonal antibody, combined with Cisplatin and Gemcitabine for the first line treatment of...
First-ever Shingles Awareness Week highlights misconceptions about the risk of developing shingles among older adults, and the need for more education
GSK has launched the inaugural Shingles Awareness Week to educate the general public about shingles in collaboration with the International Federation on Ageing Over 90% of adults, above the age of 50, already carry the virus that causes shingles, and 1 in 3 adults will develop shingles in their lifetime Yet, in a global survey of...
ALPS PHARMA LAUNCHES A NEW QUERCETIN DELIVERY COMPOSITION
HIDA, Japan, Feb. 28, 2022 /PRNewswire/ -- ALPS Pharmaceutical Ind. Co., Ltd. (President: Osamu Ushimaru), a global pharmaceutical company pioneering phytochemicals in medicine and food, today announced the launch of a water-soluble Quercetin delivery composition, Eubioflavonoid® derived from Sophora Japonica, which delivers more Quercetin to the body in a smaller dose. Eubioflavonoid®, a Quercetin delivery formula protected by three related...
ALPS PHARMA LAUNCHES A NEW WATER-SOLUBLE ISOQUERCETIN COMPOSITION WITH HIGHER ABSORPTION RATE
HIDA, Japan, Feb. 28, 2022 /PRNewswire/ -- ALPS Pharmaceutical Ind. Co., Ltd. (President: Osamu Ushimaru), a global pharmaceutical company that pioneered the use of phytochemicals in medicine and food, announced the launch of a new Isoquercetin composition, Eubio®Isoquercetin, today. Eubio®Isoquercetin derived from Sophora Japonica is expected to deliver more Quercetin to the body via small doses of Isoquercetin....
